Showing results (1-10 of 177) with videos related to
Sort By:
Pageof 18
Expert Opinion on Emerging Drugs|March 7, 2009
Emerging drugs in chronic obstructive pulmonary diseaseCarola Seifart, Claus VogelmeierRespiration; International Review of Thoracic Diseases|August 19, 2004
Exposure of differentiated airway epithelial cells to volatile smoke in vitroChristoph Beisswenger, Juliane Platz, Carola Seifart, et al.Disease Markers|November 9, 2005
TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancerCarola Seifart, Alexandra Plagens, Astrid Dempfle, et al.Toxicology and Applied Pharmacology|February 8, 2005
Cell-specific modulation of surfactant proteins by ambroxol treatmentCarola Seifart, Ursula Clostermann, Ulf Seifart, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2024
Rethinking parameters of "success" in breaking bad news conversations from patient's perspective: the successful delivery process modelMartin Koch, Carola SeifartInternational Journal of Chronic Obstructive Pulmonary Disease|February 14, 2008
Genetics of chronic obstructive pulmonary diseaseCarola Seifart, Alexandra PlagensRespiration; International Review of Thoracic Diseases|October 8, 2005
The lung, an organ for absorption?Peter von Wichert, Carola SeifartTherapeutic Advances in Respiratory Disease|April 23, 2011
NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary diseaseClaus Vogelmeier, Donald BanerjiExpert Review of Respiratory Medicine|July 14, 2012
Future of chronic obstructive pulmonary disease managementAnthony D'Urzo, Claus VogelmeierJournal of Pain and Symptom Management|November 28, 2023
Questionnaires About the End of Life for Cancer Patients - Is the Response Burden Acceptable?Liv Betker, Carola Seifart, Pia von BlanckenburgPageof 18